---
category: news
title: "Oncohost platform predicts response to lung cancer therapy"
excerpt: "Prophet, Oncohost Ltd.â€™s artificial intelligence-driven proteomics profiling platform, predicted response to immune checkpoint inhibitor (ICI) therapy in non-small-cell lung carcinoma (NSCLC) patients in a study presented at the European Society for Medical Oncology Virtual Congress 2021."
publishedDateTime: 2021-09-20T00:00:00Z
originalUrl: "https://www.bioworld.com/articles/511600-oncohost-platform-predicts-response-to-lung-cancer-therapy"
webUrl: "https://www.bioworld.com/articles/511600-oncohost-platform-predicts-response-to-lung-cancer-therapy"
type: article
quality: 39
heat: 39
published: false

provider:
  name: BioWorld
  domain: bioworld.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.bioworld.com/ext/resources/BMT-source/2020/11-4-Oncohost.png?height=635&t=1604528773&width=1200"
    width: 847
    height: 635
    isCached: true

secured: "mxXvUv/65uMPqziqIX0bM8aNPMmrOplX+L+AEQP15nUiosbDc0eKOA3eLRePa7ympeX5aaE0pozPfxcZg/y8VGgfomAFlfPyOY7vKEB9h3ajmg4Jdp8VmXnEWcrZ55wnIsS8MgSua4wFORYw924sgtGtHfvb6dv28tu3iuOMJPZoXFta5JxcNFpERo385nJbzfNvUCx2W5QrwZt7ocMb8CjPitwfJsTQdLB+5Hfb+L5jPMk5GVPuaMx2qt6y4QETErSnv/jAqMAO4LBdurjjX1OvFxgyTQMn/gnnrVjaomcWUudtBgiHWjfd6A1lFX6TghMTz+At77PVAxSFG6sZztedBA8n2Z3Lt2gguXbhYtU=;SsnmBX3fMbXS83b/ZkaMUw=="
---

